TNXP RSI Chart
Last 7 days
17.7%
Last 30 days
25%
Last 90 days
-47.4%
Trailing 12 Months
-89.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 3.9M | 0 | 5.8M | 7.8M |
2022 | 0 | 0 | 0 | 1.9M |
2011 | 0 | 0 | 5.2K | 0 |
2010 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 29, 2022 | lederman seth | bought | 34,200 | 1.71 | 20,000 | chief executive officer |
Mar 25, 2022 | lederman seth | bought | 24,500 | 0.245 | 100,000 | chief executive officer |
Sep 28, 2021 | lederman seth | bought | 7,320 | 0.61 | 12,000 | chief executive officer |
Jun 30, 2021 | saenger bradley | acquired | 10,583 | 0.58 | 18,248 | chief financial officer |
Jun 30, 2021 | sullivan gregory m | acquired | 21,167 | 0.58 | 36,496 | chief medical officer |
May 25, 2021 | goodman daniel wintner | bought | 5,600 | 1.12 | 5,000 | - |
Mar 24, 2021 | lederman seth | bought | 22,087 | 1.32 | 16,733 | chief executive officer |
Jan 07, 2021 | sullivan gregory m | acquired | 21,074 | 0.51 | 41,322 | chief medical officer |
Dec 30, 2020 | lederman seth | bought | 23,800 | 0.68 | 35,000 | chief executive officer |
Aug 31, 2020 | treco james | bought | 4,895 | 0.89 | 5,500 | - |
Which funds bought or sold TNXP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | First Western Trust Bank | unchanged | - | -2,239 | 1,920 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | new | - | 2,553 | 2,553 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -6,771 | 5,805 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -76.92 | -15.00 | 1.00 | -% |
May 15, 2024 | Federation des caisses Desjardins du Quebec | new | - | 10.00 | 10.00 | -% |
May 15, 2024 | Beaird Harris Wealth Management, LLC | sold off | -100 | -6.00 | - | -% |
May 15, 2024 | Altium Capital Management LP | sold off | -100 | -217,630 | - | -% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | reduced | -87.03 | -1,428,360 | 90,954 | -% |
May 15, 2024 | SABBY MANAGEMENT, LLC | added | 58.16 | -336,894,000 | 910,649,000 | 0.52% |
May 15, 2024 | Tower Research Capital LLC (TRC) | new | - | 6,400 | 6,400 | -% |
Unveiling Tonix Pharmaceuticals Holding Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Tonix Pharmaceuticals Holding Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Tonix Pharmaceuticals Holding Corp News
Income Statement (Quarterly) | ||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q1 | 2022Q4 | 2011Q3 | 2011Q2 | 2010Q3 | 2010Q2 |
Revenue | -34.3% | 2,482 | 3,779 | 3,989 | 2,660 | 1,330 | 1.00 | 1.00 | 1.00 | 2.00 |
Cost Of Revenue | -29.9% | 1,660 | 2,367 | 2,374 | - | - | - | - | - | - |
Costs and Expenses | -23.4% | 23,833 | 31,108 | 32,136 | 33,902 | 32,728 | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | 1,014 | 356 | - | - |
S&GA Expenses | -19.9% | 9,310 | 11,622 | 8,712 | 7,391 | 8,054 | - | - | - | - |
R&D Expenses | -24.9% | 12,863 | 17,119 | 21,050 | 26,511 | 24,674 | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | 8* | 22* | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - |
Net Income | 45.3% | -14,939 | -27,322 | -27,975 | -33,005 | -31,680 | - | - | - | - |
Net Income Margin | 15.5% | -12.69* | -15.02* | -20.77* | -30.05* | -56.64* | - | - | - | - |
Free Cashflow | 22.4% | -17,683 | -22,778 | -25,198 | -36,710 | -26,972 | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -12.4% | 135 | 154 | 139 | 160 | 179 | 226 | 243 | 276 | 224 | 241 | 215 | 189 | 184 | 98.00 | 68.00 | 58.00 | 34.00 | 15.00 | 12.00 | 15.00 | 20.00 |
Current Assets | -37.0% | 30.00 | 48.00 | 31.00 | 51.00 | 84.00 | 131 | 151 | 192 | 153 | 189 | 195 | 177 | 173 | 88.00 | 62.00 | 58.00 | 33.00 | 14.00 | 12.00 | 14.00 | 19.00 |
Cash Equivalents | -68.1% | 8.00 | 25.00 | 7.00 | 26.00 | 72.00 | 120 | 140 | 145 | 140 | 179 | 183 | 166 | 164 | 77.00 | 56.00 | 55.00 | 31.00 | 11.00 | 10.00 | 12.00 | 17.00 |
Inventory | -9.4% | 12.00 | 14.00 | 13.00 | 14.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | -1.0% | 93.00 | 94.00 | 95.00 | 96.00 | 94.00 | 94.00 | 90.00 | 83.00 | 70.00 | 51.00 | 18.00 | 10.00 | 9.00 | 9.00 | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 0% | 1.00 | 1.00 | 1.00 | 1.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | -44.4% | 27.00 | 49.00 | 18.00 | 19.00 | 14.00 | 19.00 | 14.00 | 16.00 | 16.00 | 22.00 | 13.00 | 9.00 | 7.00 | 11.00 | 5.00 | 5.00 | 3.00 | 5.00 | 2.00 | 2.00 | 2.00 |
Current Liabilities | 8.4% | 20.00 | 19.00 | 18.00 | 18.00 | 13.00 | 18.00 | 13.00 | 16.00 | 15.00 | 22.00 | 12.00 | 8.00 | 6.00 | 10.00 | 4.00 | 5.00 | 3.00 | 5.00 | 2.00 | 2.00 | 2.00 |
Long Term Debt | -6.1% | 6.00 | 7.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Current | 20.0% | 3.00 | 2.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 7.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 2.5% | 108 | 106 | 121 | 140 | 165 | 207 | 229 | 228 | 208 | 219 | 202 | 180 | 177 | 88.00 | 63.00 | 54.00 | 31.00 | 9.00 | 10.00 | 13.00 | 18.00 |
Retained Earnings | -2.5% | -615 | -600 | -573 | -545 | -516 | -470 | -438 | -409 | -386 | -359 | -330 | -311 | -288 | -267 | -250 | -238 | -224 | -217 | -208 | -200 | -194 |
Additional Paid-In Capital | 2.5% | 724 | 706 | 694 | 686 | 683 | 677 | 667 | 638 | 594 | 579 | 532 | 492 | 465 | 355 | 313 | 292 | 256 | 227 | 218 | 213 | 213 |
Shares Outstanding | 44.1% | 84.00 | 59.00 | 18.00 | 11.00 | 10.00 | 12.00 | 7.00 | 4.00 | 3.00 | 3.00 | 2.00 | 2.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 17.00 | - | - | - | 50.00 | - | - | - | 384 | - | - | - | 63,914 | - | - | - | 7,273 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 21.3% | -17,575 | -22,340 | -23,385 | -23,367 | -32,911 | -22,301 | -23,535 | -21,171 | -31,046 | -22,445 | -12,946 | -19,108 | -21,058 | -13,914 | -15,285 | -10,041 | -9,326 | -6,683 | -6,645 | -4,713 | -8,642 |
Share Based Compensation | -17.0% | 1,692 | 2,038 | 2,079 | 2,364 | 2,794 | 2,716 | 2,765 | 2,813 | 2,620 | 2,296 | 2,302 | 2,089 | 1,212 | 871 | 912 | 733 | 360 | 359 | 362 | 431 | 305 |
Cashflow From Investing | 74.9% | -108 | -431 | -821 | -24,019 | -3,799 | -4,671 | -8,820 | -14,439 | -20,217 | -25,622 | -7,751 | -1,429 | -505 | -4,534 | -4,016 | - | - | -5.00 | -2.00 | -3.00 | -7.00 |
Cashflow From Financing | -100.5% | -212 | 40,714 | 6,274 | 1,029 | -11,500 | 7,229 | -4,625 | 72,177 | 13,063 | 43,767 | 37,961 | 22,049 | 108,710 | 39,859 | 20,069 | 34,420 | 28,757 | 7,914 | 4,515 | 417 | 73.00 |
Buy Backs | - | - | - | - | - | 13,965 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
REVENUES: | ||
Product revenue, net | $ 2,482 | |
COSTS AND EXPENSES: | ||
Cost of sales | 1,660 | |
Research and development | 12,863 | 26,511 |
General and administrative | 9,310 | 7,391 |
Total operating expenses | 23,833 | 33,902 |
Operating loss | (21,351) | (33,902) |
Gain on change in fair value of warrant liabilities | 7,005 | |
Other (expense) income, net | (593) | 897 |
Net loss available to common stockholders | $ (14,939) | $ (33,005) |
Net loss per common share, basic | $ (0.18) | $ (3.21) |
Net loss per common share, diluted | $ (0.18) | $ (3.21) |
Weighted average common shares outstanding, basic | 80,879,108 | 10,268,500 |
Weighted average common shares outstanding, diluted | 80,879,108 | 10,268,500 |
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 7,049 | $ 24,948 |
Inventory, net | 12,351 | 13,639 |
Prepaid expenses and other current assets | 10,698 | 9,181 |
Total current assets | 30,098 | 47,768 |
Property and equipment, net | 93,058 | 94,028 |
Intangible assets, net | 9,505 | 9,743 |
Goodwill | 965 | 965 |
Operating lease right-to-use assets | 757 | 824 |
Other non-current assets | 960 | 1,129 |
Total assets | 135,343 | 154,457 |
Current liabilities: | ||
Accounts payable | 6,649 | 3,782 |
Accrued expenses and other current liabilities | 10,733 | 12,482 |
Term loan payable, short term | 2,820 | 2,350 |
Lease liability, short term | 277 | 270 |
Total current liabilities | 20,479 | 18,884 |
Term loan payable, long term | 6,158 | 6,561 |
Lease liability, long term | 563 | 632 |
Total liabilities | 27,200 | 48,932 |
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; 5,000,000 shares authorized, 0 shares designated as of both March 31, 2024, and December 31, 2023; 0 shares issued and outstanding - as of both March 31, 2024 and December 31, 2023 | ||
Common stock, $0.001 par value; 1,000,000,000 shares authorized; 73,724,196 and 58,614,593 shares issued and outstanding as of March 31, 2024, and December 31, 2023, respectively and 66,359 shares to be issued as of December 31, 2023 | 74 | 59 |
Additional paid in capital | 723,906 | 706,356 |
Accumulated deficit | (615,597) | (600,658) |
Accumulated other comprehensive loss | (240) | (232) |
Total stockholders’ equity | 108,143 | 105,525 |
Total liabilities and stockholders’ equity | 135,343 | 154,457 |
Series C Warrant [Member] | ||
Warrant liabilities | 14,595 | |
Series D Warrant [Member] | ||
Warrant liabilities | $ 8,260 |